All Stories

  1. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  2. Editorial: Treatment of comorbidities of asthma and its safety
  3. Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
  4. Hypersensitivity Pneumonitis: Challenges of a Complex Disease
  5. Medical students’ perceptions towards artificial intelligence in education and practice: A multinational, multicenter cross-sectional study
  6. Israel−Palestine Conflict: Risk of Sleep Disorders and Post-Traumatic Stress Disorders
  7. Promising treatment biomarkers in asthma
  8. Complications of tracheobronchial foreign body aspiration in children
  9. The Burden of Comorbidities in Obstructive Sleep Apnea and the Pathophysiologic Mechanisms and Effects of CPAP
  10. Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition
  11. Prevalence and Burden of Comorbidities in Obstructive Sleep Apnea Syndrome
  12. Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova
  13. Updates in screening for tuberculosis. Review of guidelines
  14. Diagnostic challenges of a rare disease with an unusual presentation
  15. Peripheral neuropathy: A neglected cause of disability in COPD – A narrative review
  16. Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials
  17. COPD and Diabetes Mellitus: Down the Rabbit Hole
  18. Scientists Against War: A Plea to World Leaders for Better Governance
  19. COPD and comorbidities in the Republic of Moldova
  20. Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
  21. Asthma and obstructive sleep apnoea in adults and children – an up-to-date review
  22. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
  23. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review
  24. The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea
  25. Multidimensional indices in the assessment of chronic obstructive pulmonary disease
  26. Asthma-COPD Overlap: A more Simplistic Approach
  27. Chronic obstructive disease and comorbidities (literature review)
  28. Current Approaches to Asthma In 2021
  29. A rare case of intrathymic epidermoid cyst
  30. Asthma and stroke: a narrative review
  31. Adenoid hypertrophy can impact craniofacial growth and lead to obstructive sleep apnea in children
  32. Coenzyme Q10 suplement in chronic obstructive pulmonary disease
  33. Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
  34. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
  35. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
  36. Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
  37. Current Approaches to COPD in 2019
  38. “Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.”
  39. Spontaneous Pneumomediastinum – a Rare Asthma Complication
  40. Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD
  41. Identification of clinical phenotypes using cluster analyses in COPD patients
  42. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
  43. A MULTILATERAL APPROACH TO COPD COMORBIDITIES
  44. EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD)
  45. COPD and Stroke
  46. Health-related quality of life in different phenotypes of COPD
  47. Assessment of health-related quality of life in different phenotypes of COPD
  48. Bode index in different phenotypes of COPD
  49. To sleep, or not to sleep?
  50. ACOS: current evidence and future research directions
  51. Phenotyping Before Starting Treatment in COPD?
  52. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
  53. Exercise-Induced Pulmonary Edema in Athletes
  54. Editorial: "COPD: More than a Moving Target!"
  55. P51 Clinical effectiveness of procalcitonin based protocols to guide the administration of antibiotics in patients presenting with COPD exacerbations: systematic review and meta-analysis
  56. Prevalence and burden of comorbidities in COPD
  57. Meet Our Assistant Editor
  58. Editorial: Continuous Positive Airway Pressure: Life-Saving Technology
  59. Health-Related Quality of Life in Patients with COPD
  60. Obstructive Sleep Apnea and Hypertension: A Bidirectional Causal Relation
  61. Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction
  62. Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea
  63. Editorial from Guest Editor: Current Management of Sleep Apnea and Comorbidities
  64. COPD Phenotypes and Biomarkers: Introducing Personalised Medicine
  65. Management of Stable COPD: An Update
  66. Defining COPD
  67. Imaging for diagnosis and management of tuberculosis